| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 139, 1291-1296, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
MF Prescott, RL Webb and MA Reidy
Research Department, Ciba-Geigy Corporation, Summit, New Jersey 07901.
The angiotensin-converting enzyme (ACE) inhibitor, benazeprilat and the angiotensin II (Ang II), AT1-specific receptor antagonist, DuP753, were compared for their effects on intimal lesion formation as well as smooth muscle cell (SMC) proliferation and migration in Sprague Dawley rats after carotid balloon injury. Both the ACE inhibitor (benazeprilat, 3 mg/kg/day) and the AT1 antagonist (DuP 753, 10 mg/kg/day) significantly reduced intimal lesion formation after balloon injury (by 35% and 49%, respectively). Medial SMC proliferation after injury was reduced 53% by the AT1 antagonist; however, the ACE inhibitor had no effect on SMC proliferation. SMC migration was reduced 94% by the AT1 antagonist and 68% by the ACE inhibitor. These data demonstrate the importance of Ang II in SMC proliferation and migration after balloon injury. They also demonstrate that in the balloon injury model, the ACE inhibitor reduced intimal lesion size by inhibiting SMC migration alone without affecting SMC proliferation. A more pronounced reduction in lesion size was obtained after AT1 antagonism, however, when both SMC migration and proliferation were inhibited.
This article has been cited by other articles:
![]() |
R. Zhang, Y. Wu, M. Zhao, C. Liu, L. Zhou, S. Shen, S. Liao, K. Yang, Q. Li, and H. Wan Role of HIF-1{alpha} in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L631 - L640. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huang, J. C. Thompson, P. G. Wilson, H. H. Aung, J. C. Rutledge, and L. R. Tannock Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development J. Lipid Res., March 1, 2008; 49(3): 521 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, C. Zhang, S. Schaefer, A. Estes, and K. U. Malik ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2592 - H2601. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Dourron, G. M. Jacobson, J. L. Park, J. Liu, D. J. Reddy, M. L. Scheel, and P. J. Pagano Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H946 - H953. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J Wagenaar, A. J van Boven, A. C van der Wal, G. Amoroso, R. A Tio, C. M van der Loos, A. E Becker, and W. H van Gilst Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries Cardiovasc Res, October 1, 2003; 59(4): 980 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Tallant and M. A. Clark Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7) Hypertension, October 1, 2003; 42(4): 574 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Jacobson, H. M. Dourron, J. Liu, O. A. Carretero, D. J. Reddy, T. Andrzejewski, and P. J. Pagano Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery Circ. Res., April 4, 2003; 92(6): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Taubman Angiotensin II: A Vasoactive Hormone With Ever-Increasing Biological Roles Circ. Res., January 10, 2003; 92(1): 9 - 11. [Full Text] [PDF] |
||||
![]() |
S. Kim, Y. Izumi, Y. Izumiya, Y. Zhan, M. Taniguchi, and H. Iwao Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1299 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jorgensen, H. Kelbaek, S. Helqvist, G. V. H. Jensen, K. Saunamaki, J. Kastrup, O. Havndrup, H. Bundgaard, J. Kyst Madsen, M. Christiansen, et al. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1434 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Tong Chuang Feng, Wang Yui Ying, Ren Jang Hua, Y. Y Ji, and M. de Gasparo Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1): 19 - 24. [Abstract] [PDF] |
||||
![]() |
I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S. L. Rook, K. Suzuma, E. P. Feener, and L. P. Aiello Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension Diabetes, February 1, 2001; 50(2): 444 - 454. [Abstract] [Full Text] |
||||
![]() |
R. Shibata, H. Kai, Y. Seki, S. Kato, M. Morimatsu, K. Kaibuchi, and T. Imaizumi Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury Circulation, January 16, 2001; 103(2): 284 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
Jianhua Zhu and Danchen Gao Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 278 - 282. [Abstract] [PDF] |
||||
![]() |
Y. Seki, H. Kai, R. Shibata, T. Nagata, H. Yasukawa, A. Yoshimura, and T. Imaizumi Role of the JAK/STAT Pathway in Rat Carotid Artery Remodeling After Vascular Injury Circ. Res., July 7, 2000; 87(1): 12 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Gasparo New basic science initiatives with the angiotensin II receptor blocker valsartan Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2_suppl): S3 - S5. [Abstract] [PDF] |
||||
![]() |
K. Yasunari, M. Kohno, H. Kano, M. Minami, and J. Yoshikawa Dopamine as a Novel Antioxidative Agent for Rat Vascular Smooth Muscle Cells Through Dopamine D1-Like Receptors Circulation, May 16, 2000; 101(19): 2302 - 2308. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lemay, P. Hamet, and D. deBlois Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injury Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 46 - 50. [Abstract] [PDF] |
||||
![]() |
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Holm, C. B. Andersen, S. Haunso, and P. Riis Hansen ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries Cardiovasc Res, February 1, 2000; 45(3): 777 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takeda, T. Ichiki, Y. Funakoshi, K. Ito, and A. Takeshita Downregulation of Angiotensin II Type 1 Receptor by All-trans Retinoic Acid in Vascular Smooth Muscle Cells Hypertension, January 1, 2000; 35(1): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Tallant, D. I. Diz, and C. M. Ferrario Antiproliferative Actions of Angiotensin-(1-7) in Vascular Smooth Muscle Hypertension, October 1, 1999; 34(4): 950 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Harada, Y. Toki, Y. Numaguchi, H. Osanai, T. Ito, K. Okumura, and T. Hayakawa Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications Cardiovasc Res, August 1, 1999; 43(2): 481 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Funakoshi, T. Ichiki, K. Ito, and A. Takeshita Induction of Interleukin-6 Expression by Angiotensin II in Rat Vascular Smooth Muscle Cells Hypertension, July 1, 1999; 34(1): 118 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Nugent, C. Rogers, and E. R. Edelman Endothelial Implants Inhibit Intimal Hyperplasia After Porcine Angioplasty Circ. Res., March 5, 1999; 84(4): 384 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G Hutchinson, L. Hein, M. Fujinaga, and R. E Pratt Modulation of vascular development and injury by angiotensin II Cardiovasc Res, March 1, 1999; 41(3): 689 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, I. Komuro, T. Sugaya, K. Murakami, and Y. Yazaki Vascular Injury Causes Neointimal Formation in Angiotensin II Type 1a Receptor Knockout Mice Circ. Res., February 5, 1999; 84(2): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Xi, K. Graf, S. Goetze, E. Fleck, W. A. Hsueh, and R. E. Law Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Strawn, C. M. Ferrario, and E. A. Tallant Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury Hypertension, January 1, 1999; 33(1): 207 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Melaragno, D. A. Wuthrich, V. Poppa, D. Gill, V. Lindner, B. C. Berk, and M. A. Corson Increased Expression of Axl Tyrosine Kinase After Vascular Injury and Regulation by G Protein–Coupled Receptor Agonists in Rats Circ. Res., October 5, 1998; 83(7): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Su, D. M. Lombardi, J. Siegal, and S. M. Schwartz Angiotensin II Induces Vascular Smooth Muscle Cell Replication Independent of Blood Pressure Hypertension, June 1, 1998; 31(6): 1331 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Dilley and M. I. Nataatmadja Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats Cardiovasc Res, April 1, 1998; 38(1): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Otani, H. Takagi, K. Suzuma, and Y. Honda Angiotensin II Potentiates Vascular Endothelial Growth Factor–Induced Angiogenic Activity in Retinal Microcapillary Endothelial Cells Circ. Res., March 23, 1998; 82(5): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Su, D. M. Lombardi, J. Wiener, M. J. A. P. Daemen, M. A. Reidy, and S. M. Schwartz Mitogenic Effect of Angiotensin II on Rat Carotid Arteries and Type II or III Mesenteric Microvessels but Not Type I Mesenteric Microvessels Is Mediated by Endogenous Basic Fibroblast Growth Factor Circ. Res., February 23, 1998; 82(3): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Freeman, M. L. Ruehr, and R. V. Dorman ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells Am J Physiol Cell Physiol, January 1, 1998; 274(1): C282 - C288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bennett, V. Lindner, D. DeBlois, M. A. Reidy, and S. M. Schwartz Effect of Phosphorothioated Oligonucleotides on Neointima Formation in the Rat Carotid Artery : Dissecting the Mechanism of Action Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2326 - 2332. [Abstract] [Full Text] |
||||
![]() |
J.-i. Abe, J.-o Deguchi, T. Matsumoto, N. Takuwa, M. Noda, M. Ohno, M. Makuuchi, K. Kurokawa, and Y. Takuwa Stimulated Activation of Platelet-Derived Growth Factor Receptor In Vivo in Balloon-Injured Arteries : A Link Between Angiotensin II and Intimal Thickening Circulation, September 16, 1997; 96(6): 1906 - 1913. [Abstract] [Full Text] |
||||
![]() |
J. Wong, C. Rauhoft, R. J. Dilley, A. Agrotis, G. L. Jennings, and A. Bobik Angiotensin-Converting Enzyme Inhibition Abolishes Medial Smooth Muscle PDGF-AB Biosynthesis and Attenuates Cell Proliferation in Injured Carotid Arteries : Relationships to Neointima Formation Circulation, September 2, 1997; 96(5): 1631 - 1640. [Abstract] [Full Text] |
||||
![]() |
M. S. Fernandez-Alfonso, P. A. Martorana, I. Licka, P. van Even, D. Trobisch, B. A. Scholkens, and M. Paul Early Induction of Angiotensin I–Converting Enzyme in Rat Carotid Artery After Balloon Injury Hypertension, August 1, 1997; 30(2): 272 - 277. [Abstract] [Full Text] |
||||
![]() |
G. Liu, E. Espinosa, B. S. Oemar, and T. F. Luscher Bimodal Effects of Angiotensin II on Migration of Human and Rat Smooth Muscle Cells : Direct Stimulation and Indirect Inhibition Via Transforming Growth Factor-ß1 Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1251 - 1257. [Abstract] [Full Text] |
||||
![]() |
H. Sasamura, Y. Nakazato, T. Hayashida, Y. Kitamura, M. Hayashi, and T. Saruta Regulation of Vascular Type 1 Angiotensin Receptors by Cytokines Hypertension, July 1, 1997; 30(1): 35 - 41. [Abstract] [Full Text] |
||||
![]() |
M. Kohno, K. Yokokawa, H. Kano, K. Yasunari, M. Minami, T. Hanehira, and J. Yoshikawa Adrenomedullin Is a Potent Inhibitor of Angiotensin II–Induced Migration of Human Coronary Artery Smooth Muscle Cells Hypertension, June 1, 1997; 29(6): 1309 - 1313. [Abstract] [Full Text] |
||||
![]() |
N. Iwai, M. Izumi, T. Inagami, and M. Kinoshita Induction of Renin in Medial Smooth Muscle Cells by Balloon Injury Hypertension, April 1, 1997; 29(4): 1044 - 1050. [Abstract] [Full Text] |
||||
![]() |
E. Allaire and A. W. Clowes Endothelial Cell Injury in Cardiovascular Surgery: The Intimal Hyperplastic Response Ann. Thorac. Surg., February 1, 1997; 63(2): 582 - 591. [Abstract] [Full Text] |
||||
![]() |
G. Nickenig, A. Sachinidis, F. Michaelsen, M. Bohm, S. Seewald, and H. Vetter Upregulation of Vascular Angiotensin II Receptor Gene Expression by Low-Density Lipoprotein in Vascular Smooth Muscle Cells Circulation, January 21, 1997; 95(2): 473 - 478. [Abstract] [Full Text] |
||||
![]() |
D. deBlois, D. M. Lombardi, E. J. Su, A. W. Clowes, S. M. Schwartz, and C. M. Giachelli Angiotensin II Induction of Osteopontin Expression and DNA Replication in Rat Arteries Hypertension, December 1, 1996; 28(6): 1055 - 1063. [Abstract] [Full Text] |
||||
![]() |
F. H. Messerli, M. A. Weber, and H. R. Brunner Angiotensin II Receptor Inhibition: A New Therapeutic Principle Arch Intern Med, September 23, 1996; 156(17): 1957 - 1965. [Abstract] [PDF] |
||||
![]() |
E. M. van Kleef, J. Fingerle, and M. J.A.P. Daemen Angiotensin II-Induced Progression of Neointimal Thickening in the Balloon-Injured Rat Carotid Artery Is AT1 Receptor Mediated Arterioscler Thromb Vasc Biol, July 1, 1996; 16(7): 857 - 863. [Abstract] [Full Text] |
||||
![]() |
E. J. Freeman, G. M. Chisolm, C. M. Ferrario, and E. A. Tallant Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth Hypertension, July 1, 1996; 28(1): 104 - 108. [Abstract] [Full Text] |
||||
![]() |
W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. Fujita, I. I. Stabilito, D. Kim, D. L. Ondeyka, et al. Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis Circulation, March 1, 1996; 93(5): 1009 - 1019. [Abstract] [Full Text] |
||||
![]() |
D. H. Munzenmaier and A. S. Greene Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure Hypertension, March 1, 1996; 27(3): 760 - 765. [Abstract] [Full Text] |
||||
![]() |
J. Sang Park, Seung Nam Kim, Jong Man Won, Yong Bok Koh, and In Chul Kim Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury Angiology, January 1, 1996; 47(1): 9 - 14. [Abstract] [PDF] |
||||
![]() |
J. Fingerle, R. M.K. Muller, H. Kuhn, M. Pech, and H. R. Baumgartner Mechanism of Inhibition of Neointimal Formation by the Angiotensin-Converting Enzyme Inhibitor Cilazapril : A Study in Balloon Catheter–Injured Rat Carotid Arteries Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1945 - 1950. [Abstract] [Full Text] |
||||
![]() |
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text] |
||||
![]() |
S. Kim, M. Kawamura, H. Wanibuchi, K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, and H. Iwao Angiotensin II Type 1 Receptor Blockade Inhibits the Expression of Immediate-Early Genes and Fibronectin in Rat Injured Artery Circulation, July 1, 1995; 92(1): 88 - 95. [Abstract] [Full Text] |
||||
![]() |
M. J.A.P. Daemen and J. G.R. De Mey Regional Heterogeneity of Arterial Structural Changes Hypertension, April 1, 1995; 25(4): 464 - 473. [Abstract] [Full Text] |
||||
![]() |
C. Chassagne, C. Adamy, P. Ratajczak, B. Gingras, E. Teiger, E. Planus, P. Oliviero, L. Rappaport, J.-L. Samuel, and S. Meloche Angiotensin II AT2 receptor inhibits smooth muscle cell migration via fibronectin cell production and binding Am J Physiol Cell Physiol, April 1, 2002; 282(4): C654 - C664. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |